Standout Papers

Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicen... 2018 2026 2020 2023 366
  1. Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study (2018)
    Theodore W. Laetsch, Steven G. DuBois et al. The Lancet Oncology

Immediate Impact

1 from Science/Nature 61 standout
Sub-graph 1 of 23

Citing Papers

Pancreatic cancer
2025 Standout
Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers
2024 Standout
2 intermediate papers

Works of Catherine M. Albert being referenced

Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study
2018 Standout

Author Peers

Author Last Decade Papers Cites
Catherine M. Albert 610 180 386 255 30 968
Ramamoorthy Nagasubramanian 427 154 360 187 31 1.0k
Paolo Cotzia 431 131 357 110 33 1.1k
Xiaopei Zhu 476 170 351 106 21 1.1k
Max M. van Noesel 227 119 283 259 42 1.0k
Paola Aimone 331 88 521 150 43 1.1k
Matthias Bieg 360 215 172 124 21 904
Isabelle Nanni 298 59 358 127 32 973
Hyun Jung Jun 298 309 603 98 38 1.2k
Angelica Zin 629 263 213 93 38 893
Natalie Vena 408 106 368 160 15 1.0k

All Works

Loading papers...

Rankless by CCL
2026